pathological complete response | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

33,198 results for “pathological complete response”

Trials

View all 18814 →

Active, not recruiting

Predicting Pathological Complete Response in Rectal Cancer Using Machine Learning

320 participants · First posted Apr 3, 2026

Predicting Pathological Complete Response of Rectal Cancer With Magnetic Resonance(MR) Radiomics

538 participants · First posted Aug 3, 2017

Not yet recruiting

Deep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant Immunochemotherapy

1,000 participants · First posted Feb 29, 2024

Drugs

View all 137 →

RDX-002,Response

RDX-002(Response Pharmaceuticals)

DNA Damage Response (Schrödinger)

Organizations

View all 47 →

Response Biomedical Corp.

Canada

Complete Care Inc

Canada

Immune Response Biopharma, Inc.

United States

News

View all 14200 →

Nivolumab and Ipilimumab Combination Induces Pathological Complete Response in Advanced Colorectal Cancer

Candel Therapeutics Reports Breakthrough Data for CAN-3110 in Recurrent Glioblastoma with Complete Pathological Response

Radiomics Model Predicts Pathological Response to Neoadjuvant Therapy in Hepatocellular Carcinoma

Page 1 of 3320